.jpg)
.png)
Vol. 14 Issue 2
This issue sponsored by the Southeast Lipid Association Featuring: "Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids?" and "Specialized Use of a Niacin-Statin Combination in Lipid Management" more
“What a day that was” – David Byrne, Talking Heads, Stop Making Sense Last year (2015) was a transition year that expanded upon the challenges and changes the National Lipid Association (NLA) had undergone for the prior couple of years. From a national perspective, at the demand of NLA members,... more
Pamela Morris, MD, is currently an associate professor at the Medical University of South Carolina where she serves as director of the Seinsheimer Cardiovascular Health Program and co- director of Women’s Heart Care. She is also the chair of the American College of Cardiology’s Prevention of... more
The Foundation of the National Lipid Association (FNLA) supports patient and clinician educational, research, and community outreach activities that enhance and support the initiatives of the NLA in its efforts to reduce cardiovascular events and deaths related to abnormalities of cholesterol... more
.color-blue{ color: #23527c; } Acetylsalicylic acid, or aspirin, has played a central role in the secondary prevention of cardiovascular disease (CVD) for decades, but the data for primary prevention is less clear. The current recommendations are conflicting. The U.S. Preventive Services Task... more
As clinical lipidogists, the major objective of care for most of our patients is to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). All major guideline documents, including the NLA Recommendations for Patient-Centered Management of Dyslipidemia and the 2013 American College of... more
The theme of this issue of LipidSpin is “Unusual Causes of Dyslipidemia/Less Common Dyslipidemias.” Topics range from sitosterolemia, to lysosomal acid lipase deficiency, to myositis due to red yeast rice. Although not necessarily rare for many lipidologists, other topics include potential... more
This edition of the LipidSpin is an outstanding representation of how there is never a dull moment in the world of clinical lipidology. This SELA edition of LipidSpin has many outstanding lessons and insights nested within the various articles. As I read through this edition, two things stand out... more
Introduction Patients diagnosed with serious mental illness prescribed antipsychotic medications present unique challenges to healthcare providers. The use of second- generation, or atypical, antipsychotics is associated with significant adverse metabolic effects. These include weight gain,... more
An exciting new approach to treating obesity and insulin resistance involves significant carbohydrate restriction with the goal of achieving a ketogenic state that results in weight loss and improved insulin sensitivity. Many lipidologists, however, have seen frequent cases of worsening lipid and... more